The estimated Net Worth of Micah Mitchell is at least $585 Mille dollars as of 17 January 2023. Mr Mitchell owns over 15,384 units of Myomo Inc stock worth over $264,445 and over the last 6 years he sold MYO stock worth over $0. In addition, he makes $320,614 as Chief Commercial Officer at Myomo Inc.
Mr has made over 2 trades of the Myomo Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he bought 15,384 units of MYO stock worth $5,077 on 17 January 2023.
The largest trade he's ever made was buying 15,384 units of Myomo Inc stock on 17 January 2023 worth over $5,077. On average, Mr trades about 1,251 units every 30 days since 2018. As of 17 January 2023 he still owns at least 64,815 units of Myomo Inc stock.
You can see the complete history of Mr Mitchell stock trades at the bottom of the page.
Micah J. Mitchell is the Chief Commercial Officer at Myomo Inc.
As the Chief Commercial Officer of Myomo Inc, the total compensation of Mr Mitchell at Myomo Inc is $320,614. There are 2 executives at Myomo Inc getting paid more, with Paul R. Gudonis having the highest compensation of $439,710.
Mr Mitchell is 45, he's been the Chief Commercial Officer of Myomo Inc since . There are 7 older and no younger executives at Myomo Inc. The oldest executive at Myomo Inc is Clifford J. Conneighton, 71, who is the Chief Marketing Officer.
Micah's mailing address filed with the SEC is 1 Broadway, Cambridge, MA 02142, USA.
Over the last 7 years, insiders at Myomo Inc have traded over $203,224 worth of Myomo Inc stock and bought 776,898 units worth $937,925 . The most active insiders traders include Steve Sanghi, Paul R Gudonis e Heather C Getz. On average, Myomo Inc executives and independent directors trade stock every 57 days with the average trade being worth of $120,686. The most recent stock trade was executed by Harry Kovelman on 5 September 2024, trading 6,700 units of MYO stock currently worth $25,192.
myomo's mission is to enable individuals to overcome their paralysis by providing innovative, myoelectric orthotics and support services. we are committed to working with healthcare professionals to deliver high quality outcomes and patient satisfaction through research collaborations and continuing education programs. the company empowers persons with a neuromuscular disability to perform functional activities at home, at work, and in the community, resulting in an improved quality of life and lower healthcare costs.
Myomo Inc executives and other stock owners filed with the SEC include: